Better mattresses improve care, cut hospital costs

 

Toronto, Canada (August 17, 2011) — Hospitals could reduce health care costs arising from pressure ulcers, commonly known as bedsores, by investing in pressure-reduction mattresses for elderly patients in emergency departments, according to new research from the University of Toronto.

 

In emergency departments (EDs), elderly patients are at high risk for pressure ulcers in part because they spend hours lying on hard surfaces. The researchers found that while the average cost of upgrading from standard to pressure-redistribution mattresses would be 30 cents per patient, the corresponding reduction in pressure-ulcer incidence would produce savings of $32 per patient.

 

"Most pressure ulcers are preventable, which is why the U.S. Centers for Medicare and Medicaid Services considers them a ’never event‘ and won’t reimburse their treatment," said Ba‘ Pham, lead author on the study and a senior research associate with the Toronto Health Economics and Technology Assessment (THETA) Collaborative. "Upgrading mattress quality would save money and improve quality of life for elderly patients in emergency departments," said Pham, who is also completing his training at U of T’s Department of Health Policy, Management and Evaluation.

 

In their study, published in Annals of Emergency Medicine, the researchers performed a cost-effectiveness analysis based on data drawn primarily from Ontario. They compared the projected incidence of pressure ulcers based on current practices in EDs with projected incidence after introduction of better mattresses and found that early prevention was likely to be cost-effective 81% of the time.

 

As part of their study, they also conducted a small survey of Ontario EDs and found that only 12% of stretchers and beds have pressure-reduction mattresses. Annually in Ontario, about 240,000 elderly patients are admitted to EDs; the researchers‘ model suggested that providing better mattresses for these patients would prevent 1,005 pressure ulcers and save $7.2 million in health care costs.

 

"Pressure ulcers are a huge but underappreciated problem across multiple settings in our health care system," said Prof. Murray Krahn, principal investigator on the study who is a Professor in the Department of Medicine and Faculty of Pharmacy at U of T and the Director of THETA. "Though they are not the full solution, pressure-reduction mattresses are an inexpensive and easy way to address the problem, particularly among elderly patients admitted to EDs."

 

In other studies, the researchers have found potential for cost reduction through pressure-redistribution mattresses in operating rooms, long-term care homes and other facilities. Through THETA, they are working toward implementing a province-wide strategy on pressure-reduction mattresses with the Ontario Health Technology Advisory Committee (OHTAC) and the Medical Advisory Secretariat at Health Quality Ontario, an independent agency that monitors and promotes improvements in health care in Ontario.

 

Although OHTAC issued evidence-based recommendations in 2009 on preventing pressure ulcers that included use of better mattresses in EDs, operating rooms and long-term care facilities, Pham said the province and country still lack a cohesive and effective strategy. "We need active policies in Canada to transfer our knowledge into practice," said Pham. "But I expect change will happen, because the burden of pressure ulcers is so high and investing in better mattresses is virtually a one-time change."

 

 

  • This study was conducted by the following researchers: Ba‘ Pham (Toronto Health Economics and Technology Assessment Collaborative [THETA], University of Toronto), Laura Teague (Wound Care Program), Dr. James Mahoney (Division of Plastic Surgery, Department of Surgery, U of T) Laurie Goodman (Skin and Wound Care, Credit Valley Hospital), Mike Paulden (THETA), Dr. Jeff Poss (Department of Health Studies and Gerontology, University of Waterloo), Dr. Jianli Li (Decision Support Services, St. Michael’s Hospital), Luciano Ieraci (THETA), Steven Carcone (THETA), Dr. Murray Krahn (THETA).

 

  • Funding for this study was provided in part by Health Quality Ontario and the Ontario Ministry of Health and Long-Term Care through THETA. The THETA Collaborative provides technology assessment support for the Ontario Health Technology Advisory Committee and the Medical Advisory Secretariat at Health Quality Ontario.

 


 

University of Toronto, 17.08.2011 Nursing News (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…